$5.34
-0.40 (-6.97%)
Open$5.70
Previous Close$5.74
Day High$5.71
Day Low$5.34
52W High$5.89
52W Low$4.91
Volume—
Avg Volume146.3K
Market Cap35.98M
P/E Ratio—
EPS$-9.35
SectorBiotechnology
Analyst Ratings
Buy
10 analysts
Price Target
+226.6% upside
Current
$5.34
$5.34
Target
$17.44
$17.44
$9.95
$17.44 avg
$18.08
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 20.12M | 21.13M | 21.81M |
| Net Income | -133,172,516 | -3,613,419 | -4,862,244 |
| Profit Margin | -661.9% | -17.1% | -22.3% |
| EBITDA | -139,029,659 | -5,916,348 | -5,182,437 |
| Free Cash Flow | — | -5,168,786 | -3,508,220 |
| Rev Growth | +692.3% | -1.2% | +1.1% |
| Debt/Equity | — | 0.72 | 0.63 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |